Annual EBITDA
$838.64M$22.41M+2.75%
Summary
- Current Value
- As of today, TFX annual EBITDA is $838.64M, up +2.75% on
- Historical Performance
- TFX annual EBITDA is up +3.70% over the past 3 years, and up +17.06% over the past 5 years
- All-Time High Comparison
- TFX annual EBITDA is currently at its all-time high
- 3-Year Low Comparison
- TFX annual EBITDA is +7.73% above its 3-year low of $778.43M reached on an earlier date
- Sector Comparison
- TFX annual EBITDA is higher than 93.47% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $838.64M | +2.8% | +3.7% | +17.1% | +112.4% | |
| Quarterly EBITDA | $191.18M | -10.2% | +4.9% | +3.7% | +108.1% | |
| TTM EBITDA | $850.20M | +4.4% | +11.9% | +16.7% | +115.2% | |
| Price | $112.20 | -37.0% | -56.4% | -72.9% | +107.2% | |
| PE Ratio | - | – | – | – | – | |
| Annual Revenue | $3.05B | +2.5% | +8.5% | +17.4% | +61.2% | |
| Annual EPS | $1.48 | -80.4% | -85.5% | -84.9% | -80.5% | |
| Annual EBIT | $564.04M | -1.8% | -1.3% | +12.3% | +92.0% | |
| Annual Net Income | $70.16M | -80.4% | -85.5% | -84.8% | -50.9% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $838.64M | at high | |
| 5Y | $838.64M | at high | |
| All | $838.64M | at high |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $778.43M | N/A | +7.7% |
| 5Y | $731.57M | N/A | +14.6% |
| All | $11.76M | +7030.1% |
EBITDA History
FAQ
What is the current annual EBITDA of TFX?
As of today, TFX annual EBITDA is $838.64M
What is 1-year change in TFX annual EBITDA?
TFX annual EBITDA is up +2.75% year-over-year
What is 3-year change in TFX annual EBITDA?
TFX annual EBITDA is up +3.70% over the past 3 years
How far is TFX annual EBITDA from its all-time high?
TFX annual EBITDA is currently at its all-time high
How does TFX annual EBITDA rank versus sector peers?
TFX annual EBITDA is higher than 93.47% of companies in Healthcare sector
When is TFX next annual earnings release?
The next annual earnings release for TFX is on
Quarterly EBITDA
$191.18M$53.19M-21.77%
Summary
- Current Value
- As of today, TFX quarterly EBITDA is $191.18M, down -21.77% on
- Historical Performance
- TFX quarterly EBITDA is down -10.17% year-over-year, and up +4.87% over the past 3 years
- All-Time High Comparison
- TFX quarterly EBITDA is currently -27.09% below its historical high of $262.22M set on
- 3-Year Low Comparison
- TFX quarterly EBITDA is +9.89% above its 3-year low of $173.97M reached on
- Sector Comparison
- TFX quarterly EBITDA is higher than 91.60% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $191.18M | -21.8% | -10.2% | +4.9% | +3.7% | |
| Annual EBITDA | $838.64M | – | +2.8% | +3.7% | +17.1% | |
| TTM EBITDA | $850.20M | -2.5% | +4.4% | +11.9% | +16.7% | |
| Price | $112.20 | -10.0% | -37.0% | -56.4% | -72.9% | |
| PE Ratio | - | – | – | – | – | |
| Quarterly Revenue | $913.02M | +16.9% | +19.4% | +32.9% | +45.3% | |
| Quarterly EPS | -$9.24 | -434.3% | -491.5% | -528.7% | -475.3% | |
| Quarterly EBIT | $113.25M | -36.6% | -21.5% | -10.1% | -11.1% | |
| Quarterly Net Income | -$408.88M | -433.6% | -468.6% | -501.3% | -450.6% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $244.36M | -21.8% | |
| 3Y | $244.36M | -21.8% | |
| 5Y | $244.36M | -21.8% | |
| All | $262.22M | -27.1% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $191.18M | at low | |
| 3Y | $173.97M | +9.9% | |
| 5Y | $167.55M | +14.1% | |
| All | -$217.70M | +187.8% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of TFX?
As of today, TFX quarterly EBITDA is $191.18M
What is TFX quarterly EBITDA most recent change?
TFX quarterly EBITDA was down -21.77% on September 28, 2025
What is 1-year change in TFX quarterly EBITDA?
TFX quarterly EBITDA is down -10.17% year-over-year
How far is TFX quarterly EBITDA from its all-time high?
TFX quarterly EBITDA is currently -27.09% below its historical high of $262.22M set on March 29, 2020
How does TFX quarterly EBITDA rank versus sector peers?
TFX quarterly EBITDA is higher than 91.60% of companies in Healthcare sector
When is TFX next earnings release?
The next earnings release for TFX is on
TTM EBITDA
$850.20M$21.65M-2.48%
Summary
- Current Value
- As of today, TFX TTM EBITDA is $850.20M, down -2.48% on
- Historical Performance
- TFX TTM EBITDA is up +4.44% year-over-year, and up +11.86% over the past 3 years
- All-Time High Comparison
- TFX TTM EBITDA is currently -2.48% below its historical high of $871.85M set on
- 3-Year Low Comparison
- TFX TTM EBITDA is +14.09% above its 3-year low of $745.18M reached on an earlier date
- Sector Comparison
- TFX TTM EBITDA is higher than 92.59% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $850.20M | -2.5% | +4.4% | +11.9% | +16.7% | |
| Annual EBITDA | $838.64M | – | +2.8% | +3.7% | +17.1% | |
| Quarterly EBITDA | $191.18M | -21.8% | -10.2% | +4.9% | +3.7% | |
| Price | $112.20 | -10.0% | -37.0% | -56.4% | -72.9% | |
| PE Ratio | - | – | – | – | – | |
| TTM Revenue | $3.19B | +4.9% | +5.4% | +14.1% | +27.3% | |
| TTM EPS | -$7.36 | -273.2% | -246.2% | -184.4% | -194.6% | |
| TTM EBIT | $567.44M | -5.2% | +3.7% | +7.0% | +12.5% | |
| TTM Net Income | -$327.85M | -270.8% | -237.8% | -179.5% | -189.3% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $871.85M | -2.5% | |
| 3Y | $871.85M | -2.5% | |
| 5Y | $871.85M | -2.5% | |
| All | $871.85M | -2.5% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $821.74M | +3.5% | |
| 3Y | $745.18M | N/A | +14.1% |
| 5Y | $630.91M | +34.8% | |
| All | -$164.60M | +616.5% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of TFX?
As of today, TFX TTM EBITDA is $850.20M
What is TFX TTM EBITDA most recent change?
TFX TTM EBITDA was down -2.48% on September 28, 2025
What is 1-year change in TFX TTM EBITDA?
TFX TTM EBITDA is up +4.44% year-over-year
How far is TFX TTM EBITDA from its all-time high?
TFX TTM EBITDA is currently -2.48% below its historical high of $871.85M set on June 29, 2025
How does TFX TTM EBITDA rank versus sector peers?
TFX TTM EBITDA is higher than 92.59% of companies in Healthcare sector
When is TFX next earnings release?
The next earnings release for TFX is on
EBITDA Formula
EBITDA = + + +
Data Sources & References
- TFX Official Website www.teleflex.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/96943/000009694325000138/0000096943-25-000138-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/96943/000009694325000031/0000096943-25-000031-index.htm
- TFX Profile on Yahoo Finance finance.yahoo.com/quote/TFX
- TFX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/tfx